Cartesian Therapeutics, Inc. Interest Expense
Cartesian Therapeutics, Inc. (RNAC) reported Interest Expense of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-08
- Cartesian Therapeutics, Inc. interest expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. interest expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. interest expense for the quarter ending 2023-09-30 was $1.27M, a 58.73% increase year-over-year.
- Cartesian Therapeutics, Inc. interest expense for the quarter ending 2023-06-30 was $752.00K, a 5.17% increase year-over-year.
- Cartesian Therapeutics, Inc. interest expense for fiscal 2023 was $2.83M, a 6.53% decline from fiscal 2022.
- Cartesian Therapeutics, Inc. interest expense for fiscal 2022 was $3.03M, a 6.58% increase from fiscal 2021.
- Cartesian Therapeutics, Inc. interest expense for fiscal 2021 was $2.84M, a 82.78% increase from fiscal 2020.
- Cartesian Therapeutics, Inc. interest expense for fiscal 2020 was $1.56M, a 2.44% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | $1.27M derived: sum of 3 quarters · filed 2024-05-08 | $2.02M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.27M derived: sum of 2 quarters · filed 2024-03-07 | $2.02M derived: sum of 3 quarters · filed 2024-03-07 | $2.83M 10-K · filed 2024-03-07 |
| 2023-09-30 | $1.27M 10-Q · filed 2023-11-13 | $2.02M derived: sum of 2 quarters · filed 2023-11-13 | $2.83M 10-Q · filed 2023-11-13 | $3.64M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-06-30 | $752.00K 10-Q · filed 2023-08-17 | $1.56M 10-Q · filed 2023-08-17 | $2.37M derived: sum of 3 quarters · filed 2024-05-08 | $3.17M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $808.00K 10-Q · filed 2024-05-08 | $1.61M derived: sum of 2 quarters · filed 2024-05-08 | $2.42M derived: sum of 3 quarters · filed 2024-05-08 | $3.13M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.61M derived: sum of 2 quarters · filed 2024-03-07 | $2.32M derived: sum of 3 quarters · filed 2024-03-07 | $3.03M 10-K · filed 2024-03-07 |
| 2022-09-30 | $802.00K 10-Q · filed 2023-11-13 | $1.52M derived: sum of 2 quarters · filed 2023-11-13 | $2.22M 10-Q · filed 2023-11-13 | $2.94M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $715.00K 10-Q · filed 2023-08-17 | $1.42M 10-Q · filed 2023-08-17 | $2.13M derived: sum of 3 quarters · filed 2024-03-07 | $2.84M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $707.00K 10-Q · filed 2023-05-04 | $1.42M derived: sum of 2 quarters · filed 2024-03-07 | $2.13M derived: sum of 3 quarters · filed 2024-03-07 | $2.84M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.42M derived: sum of 2 quarters · filed 2024-03-07 | $2.13M derived: sum of 3 quarters · filed 2024-03-07 | $2.84M 10-K · filed 2024-03-07 |
| 2021-09-30 | $711.00K 10-Q · filed 2022-11-03 | $1.42M derived: sum of 2 quarters · filed 2022-11-03 | $2.13M 10-Q · filed 2022-11-03 | $2.85M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $711.00K 10-Q · filed 2022-08-08 | $1.42M 10-Q · filed 2022-08-08 | $2.13M derived: sum of 3 quarters · filed 2023-03-02 | $2.50M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $711.00K 10-Q · filed 2022-05-05 | $1.42M derived: sum of 2 quarters · filed 2023-03-02 | $1.79M derived: sum of 3 quarters · filed 2023-03-02 | $1.99M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.08M derived: sum of 2 quarters · filed 2023-03-02 | $1.28M derived: sum of 3 quarters · filed 2023-03-02 | $1.56M 10-K · filed 2023-03-02 |
| 2020-09-30 | $365.00K 10-Q · filed 2021-11-09 | $570.00K derived: sum of 2 quarters · filed 2021-11-09 | $843.00K 10-Q · filed 2021-11-09 | $1.18M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $205.00K 10-Q · filed 2021-08-12 | $478.00K 10-Q · filed 2021-08-12 | $813.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.20M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $273.00K 10-Q · filed 2021-05-13 | $608.00K derived: sum of 2 quarters · filed 2022-03-10 | $996.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.40M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $723.00K derived: sum of 2 quarters · filed 2022-03-10 | $1.12M derived: sum of 3 quarters · filed 2022-03-10 | $1.52M 10-K · filed 2022-03-10 |
| 2019-09-30 | $388.00K 10-Q · filed 2020-11-05 | $788.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.18M 10-Q · filed 2020-11-05 | $1.58M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $400.00K 10-Q · filed 2020-08-06 | $796.00K 10-Q · filed 2020-08-06 | $1.19M derived: sum of 3 quarters · filed 2021-03-12 | $1.57M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $396.00K 10-Q · filed 2020-05-07 | $791.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.18M derived: sum of 3 quarters · filed 2021-03-12 | $1.54M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $779.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.14M derived: sum of 3 quarters · filed 2021-03-12 | $1.49M 10-K · filed 2021-03-12 |
| 2018-09-30 | $384.00K 10-Q · filed 2019-11-08 | $749.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.10M 10-Q · filed 2019-11-08 | $1.46M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $365.00K 10-Q · filed 2019-08-08 | $715.00K 10-Q · filed 2019-08-08 | $1.07M derived: sum of 3 quarters · filed 2020-03-12 | $1.34M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $350.00K 10-Q · filed 2019-05-09 | $709.00K derived: sum of 2 quarters · filed 2020-03-12 | $977.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.26M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $359.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $627.00K derived: sum of 2 quarters · filed 2020-03-12 | $906.00K derived: sum of 3 quarters · filed 2020-03-12 | $1.21M 10-K · filed 2020-03-12 |
| 2017-09-30 | $268.00K 10-Q · filed 2018-11-08 | $547.00K derived: sum of 2 quarters · filed 2018-11-08 | $847.00K 10-Q · filed 2018-11-08 | $1.17M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $279.00K 10-Q · filed 2018-08-08 | $579.00K 10-Q · filed 2018-08-08 | $901.00K derived: sum of 3 quarters · filed 2019-03-15 | $1.21M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-09 | $622.00K derived: sum of 2 quarters · filed 2019-03-15 | $933.00K derived: sum of 3 quarters · filed 2019-03-15 | $1.24M derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $633.00K derived: sum of 2 quarters · filed 2019-03-15 | $943.00K derived: sum of 3 quarters · filed 2019-03-15 | $1.25M 10-K · filed 2019-03-15 |
| 2016-09-30 | $311.00K 10-Q · filed 2017-11-07 | $621.00K derived: sum of 2 quarters · filed 2017-11-07 | $931.00K 10-Q · filed 2017-11-07 | $1.04M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $310.00K 10-Q · filed 2017-08-11 | $620.00K 10-Q · filed 2017-08-11 | $725.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.06M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $310.00K 10-Q · filed 2017-05-11 | $415.00K derived: sum of 2 quarters · filed 2018-03-15 | $749.00K derived: sum of 3 quarters · filed 2018-03-15 | $1.08M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $439.00K derived: sum of 2 quarters · filed 2018-03-15 | $769.00K derived: sum of 3 quarters · filed 2018-03-15 | $948.00K 10-K · filed 2018-03-15 |
| 2015-09-30 | $334.00K 10-Q · filed 2016-11-10 | $664.00K derived: sum of 2 quarters · filed 2016-11-10 | $843.00K 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $330.00K 10-Q · filed 2016-08-09 | $509.00K 10-Q · filed 2016-08-09 | ||
| 2014-12-31 | $552.00K 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |